Interestingly, few of the genetic mutations discussed here are present in and influence the risk of developing breast and gynecological cancers, suggesting that some of these BARD1 SNPs may be cancer-specific (Supplementary Tables S1 and S2) [19,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150]. This evidence concerns the gene BARD1 and female reproductive organ cancer.